JPS5973522A - 脳神経細胞の酸素欠乏性疾患治療剤 - Google Patents

脳神経細胞の酸素欠乏性疾患治療剤

Info

Publication number
JPS5973522A
JPS5973522A JP18502282A JP18502282A JPS5973522A JP S5973522 A JPS5973522 A JP S5973522A JP 18502282 A JP18502282 A JP 18502282A JP 18502282 A JP18502282 A JP 18502282A JP S5973522 A JPS5973522 A JP S5973522A
Authority
JP
Japan
Prior art keywords
group
prostaglandin
active ingredient
nerve cells
anoxia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP18502282A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0129168B2 (ko
Inventor
Yoshinobu Masuda
増田　義信
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dainippon Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
Original Assignee
Dainippon Pharmaceutical Co Ltd
Ono Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co Ltd, Ono Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Priority to JP18502282A priority Critical patent/JPS5973522A/ja
Priority to DE19833315356 priority patent/DE3315356A1/de
Priority to US06/490,223 priority patent/US4499085A/en
Publication of JPS5973522A publication Critical patent/JPS5973522A/ja
Publication of JPH0129168B2 publication Critical patent/JPH0129168B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP18502282A 1982-04-30 1982-10-20 脳神経細胞の酸素欠乏性疾患治療剤 Granted JPS5973522A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP18502282A JPS5973522A (ja) 1982-10-20 1982-10-20 脳神経細胞の酸素欠乏性疾患治療剤
DE19833315356 DE3315356A1 (de) 1982-04-30 1983-04-28 Verwendung von prostaglandinanalogen
US06/490,223 US4499085A (en) 1982-04-30 1983-04-29 Method of anoxia treatment using prostaglandin analogues

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP18502282A JPS5973522A (ja) 1982-10-20 1982-10-20 脳神経細胞の酸素欠乏性疾患治療剤

Publications (2)

Publication Number Publication Date
JPS5973522A true JPS5973522A (ja) 1984-04-25
JPH0129168B2 JPH0129168B2 (ko) 1989-06-08

Family

ID=16163403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP18502282A Granted JPS5973522A (ja) 1982-04-30 1982-10-20 脳神経細胞の酸素欠乏性疾患治療剤

Country Status (1)

Country Link
JP (1) JPS5973522A (ko)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6130519A (ja) * 1984-07-23 1986-02-12 Dainippon Pharmaceut Co Ltd 脳神経細胞の酸素欠乏性疾患治療剤
JPH01502750A (ja) * 1987-03-13 1989-09-21 シエーリング　アクチエンゲゼルシヤフト ６―オキソプロスタグランジン―ｅ―誘導体、その製造法およびその医薬用途
EP0430552A2 (en) 1989-11-22 1991-06-05 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6130519A (ja) * 1984-07-23 1986-02-12 Dainippon Pharmaceut Co Ltd 脳神経細胞の酸素欠乏性疾患治療剤
JPH0443053B2 (ko) * 1984-07-23 1992-07-15 Dainippon Seiyaku Kk
JPH01502750A (ja) * 1987-03-13 1989-09-21 シエーリング　アクチエンゲゼルシヤフト ６―オキソプロスタグランジン―ｅ―誘導体、その製造法およびその医薬用途
EP0430552A2 (en) 1989-11-22 1991-06-05 Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds

Also Published As

Publication number Publication date
JPH0129168B2 (ko) 1989-06-08

Similar Documents

Publication Publication Date Title
Brendler et al. Topical oxybutynin chloride for relaxation of dysfunctional bladders
US4499085A (en) Method of anoxia treatment using prostaglandin analogues
US4470965A (en) Celiprolol for the treatment of glaucoma
JP2004075696A (ja) ２，４−ジスルホフェニルブチルニトロン、その塩および薬学的スピントラップ剤としてのそれらの使用
Chu Carbamazepine: prevention of alcohol withdrawal seizures
JPS63230628A (ja) 虚血症又は酸素欠乏症治療用組成物及び新血管形成防止又は抑制用組成物
JP5680412B2 (ja) レオヌリンの使用およびその組成物
US6720011B1 (en) Injectable composition for cancer treatment
CN1930123B (zh) 用于预防或治疗伴有神经障碍的膀胱过度活动症的医药组合物
WO2003080182A1 (de) Verwendung von cysteinprotease-inhibitoren zur behandlung von erkrankungen
JPS5973522A (ja) 脳神経細胞の酸素欠乏性疾患治療剤
WO2004039321A2 (en) Combinative nicotinic/d1 agonism therapy for the treatment of alzheimer’s disease
DE69115528T2 (de) Neue pharmazeutische Verwendungen von Forskolin-Derivaten
JPS58192821A (ja) 脳神経細胞の酸素欠乏性疾患の治療剤
CA2416600A1 (en) Freeze-dried preparation of n-¬o-(p-pivaloyloxybenzenesulfonylamino)benzoyl|glycine monosodium salt tetrahydrate and a process for the maufacture thereof
CN114796241A (zh) 一种吡啶磺酰胺磷酸酯类化合物在制备抗脑水肿药物中的用途
JPH06263636A (ja) 脳または高次神経疾患治療剤
JPS6219405B2 (ko)
CN110833553A (zh) 吡唑并嘧啶衍生物在治疗Arthus反应的用途
JP2606835B2 (ja) ショック症状及び呼吸機能障害や心臓循環機能不全を治療する為のａｃｔｈ断片を含有する薬学的組成物及び薬剤キット
JPWO2005007191A1 (ja) 医薬組成物
US3906107A (en) Aminoalkyl sulfate esters with diuretic activity
US6884819B1 (en) Neuropathy remedies
RU2696586C1 (ru) Гемопротекторное средство
DE68927885T2 (de) Verwendung von isokarbacyclinen zur vorbeugung oder behandlung von organkrankheiten